Table 3.
Antibiotics | Total R (%) | ESBL- positive (n = 7) | ESBL-negative (n = 28) | p -value | ||
---|---|---|---|---|---|---|
R (%) | S (%) | R (%) | S (%) | |||
Cefotaxime | 7 (20.0) | 6 (85.7) | 1 (14.3) | 1 (3.6) | 27 (96.4) | 0.001 |
Ceftazidime | 11 (31.4) | 5 (71.4) | 2 (28.6) | 6 (21.4) | 22 (78.6) | 0.021 |
Ceftriaxone | 6 (17.1) | 6 (85.7) | 1 (14.3) | 0 | 28 (100) | 0.001 |
AMC | 11 (31.4) | 6 (85.7) | 1 (14.3) | 5 (17.9) | 23 (82.1) | 0.002 |
Ampicillin | 35 (100) | 7 (100) | 0 | 28 (100) | 0 | – |
Penicillin | 35 (100) | 7 (100) | 0 | 28 (100) | 0 | – |
Gentamycin | 3 (8.6) | 1 (14.3) | 6 (85.7) | 2 (7.1) | 26 (92.9) | 0.499 |
Amikacin | 0 | 0 | 7 (100) | 0 | 28 (100) | – |
Ciprofloxacin | 4 (11.4) | 1 (14.3) | 6 (85.7) | 3 (10.7) | 25 (89.3) | 1.000 |
Tetracycline | 19 (54.3) | 6 (85.7) | 1 (14.3) | 13 (46.4) | 15 (53.6) | 0.096 |
SXT | 19 (54.3) | 6 (85.7) | 1 (14.3) | 13 (46.4) | 15 (53.6) | 0.096 |
Erythromycin | 35 (100) | 7 (100) | 0 | 28 (100) | 0 | – |
Neomycin | 1 | 1 (14.3) | 6 (85.7) | 0 | 28 (100) | 0.200 |
R: Resistant, S: Sensitive, AMC: Amoxicillin-clavulanic acid, SXT: Trimethoprim- sulphamethoxazole